Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study
- PMID: 31704137
- PMCID: PMC6941215
- DOI: 10.1016/S1470-2045(19)30595-9
Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study
Abstract
Background: Early diagnosis interventions such as symptom awareness campaigns increasingly form part of global cancer control strategies. However, these strategies will have little impact in improving cancer outcomes if the targeted symptoms represent advanced stage of disease. Therefore, we aimed to examine associations between common presenting symptoms of cancer and stage at diagnosis.
Methods: In this cross-sectional study, we analysed population-level data from the English National Cancer Diagnosis Audit 2014 for patients aged 25 years and older with one of 12 types of solid tumours (bladder, breast, colon, endometrial, laryngeal, lung, melanoma, oral or oropharyngeal, ovarian, prostate, rectal, and renal cancer). We considered 20 common presenting symptoms and examined their associations with stage at diagnosis (TNM stage IV vs stage I-III) using logistic regression. For each symptom, we estimated these associations when reported as a single presenting symptom and when reported together with other symptoms.
Findings: We analysed data for 7997 patients. The proportion of patients diagnosed with stage IV cancer varied substantially by presenting symptom, from 1% (95% CI 1-3; eight of 584 patients) for abnormal mole to 80% (71-87; 84 of 105 patients) for neck lump. Three of the examined symptoms (neck lump, chest pain, and back pain) were consistently associated with increased odds of stage IV cancer, whether reported alone or with other symptoms, whereas the opposite was true for abnormal mole, breast lump, postmenopausal bleeding, and rectal bleeding. For 13 of the 20 symptoms (abnormal mole, breast lump, post-menopausal bleeding, rectal bleeding, lower urinary tract symptoms, haematuria, change in bowel habit, hoarseness, fatigue, abdominal pain, lower abdominal pain, weight loss, and the "any other symptom" category), more than 50% of patients were diagnosed at stages other than stage IV; for 19 of the 20 studied symptoms (all except for neck lump), more than a third of patients were diagnosed at stages other than stage IV.
Interpretation: Despite specific presenting symptoms being more strongly associated with advanced stage at diagnosis than others, for most symptoms, large proportions of patients are diagnosed at stages other than stage IV. These findings provide support for early diagnosis interventions targeting common cancer symptoms, countering concerns that they might be simply expediting the detection of advanced stage disease.
Funding: UK Department of Health's Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis; and Cancer Research UK.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures
Comment in
-
Earlier diagnosis: the importance of cancer symptoms.Lancet Oncol. 2020 Jan;21(1):6-8. doi: 10.1016/S1470-2045(19)30658-8. Epub 2019 Nov 6. Lancet Oncol. 2020. PMID: 31704136 No abstract available.
Similar articles
-
The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.Dan Med J. 2015 Mar;62(3):B5027. Dan Med J. 2015. PMID: 25748876 Clinical Trial.
-
Socio-demographic variation in stage at diagnosis of breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, renal and ovarian cancer in England and its population impact.Br J Cancer. 2021 Mar;124(7):1320-1329. doi: 10.1038/s41416-021-01279-z. Epub 2021 Feb 9. Br J Cancer. 2021. PMID: 33564123 Free PMC article.
-
Stage-specific risk of colon and rectal cancer in patients presenting with rectal bleeding or change in bowel habit in primary care: A population-based cohort study.Cancer Epidemiol. 2023 Dec;87:102484. doi: 10.1016/j.canep.2023.102484. Epub 2023 Nov 9. Cancer Epidemiol. 2023. PMID: 37948886
-
Interventions for raising breast cancer awareness in women.Cochrane Database Syst Rev. 2017 Feb 10;2(2):CD011396. doi: 10.1002/14651858.CD011396.pub2. Cochrane Database Syst Rev. 2017. PMID: 28185268 Free PMC article. Review.
-
Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms.Nat Rev Clin Oncol. 2019 Dec;16(12):746-761. doi: 10.1038/s41571-019-0249-6. Epub 2019 Jul 26. Nat Rev Clin Oncol. 2019. PMID: 31350467 Review.
Cited by
-
Symptom impact and health-related quality of life (HRQoL) assessment by cancer stage: a narrative literature review.BMC Cancer. 2024 Jul 22;24(1):884. doi: 10.1186/s12885-024-12612-z. BMC Cancer. 2024. PMID: 39039461 Review.
-
Revisiting the symptom iceberg based on the Danish symptom cohort - Symptom experiences and healthcare-seeking behaviour in the general Danish population in 2022.Heliyon. 2024 May 13;10(10):e31090. doi: 10.1016/j.heliyon.2024.e31090. eCollection 2024 May 30. Heliyon. 2024. PMID: 38803940 Free PMC article.
-
Using an mHealth approach to collect patient-generated health data for predicting adverse health outcomes among adult survivors of childhood cancer.Front Oncol. 2024 May 10;14:1374403. doi: 10.3389/fonc.2024.1374403. eCollection 2024. Front Oncol. 2024. PMID: 38800387 Free PMC article.
-
Promising Effects of Casearins in Tumor-Bearing Mice and Antinociceptive Action against Oncologic Pain: Molecular Docking and In Vivo Findings.Pharmaceuticals (Basel). 2024 May 14;17(5):633. doi: 10.3390/ph17050633. Pharmaceuticals (Basel). 2024. PMID: 38794204 Free PMC article.
-
Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery.Molecules. 2024 May 19;29(10):2393. doi: 10.3390/molecules29102393. Molecules. 2024. PMID: 38792255 Free PMC article. Review.
References
-
- WHO . World Health Organization; Geneva: 2017. Guide to cancer: early diagnosis.http://apps.who.int/iris/bitstream/10665/254500/1/9789241511940-eng.pdf?...
-
- Ott JJ, Ullrich A, Miller AB. The importance of early symptom recognition in the context of early detection and cancer survival. Eur J Cancer. 2009;45:2743–2748. - PubMed
-
- Abuidris DO, Elsheikh A, Ali M. Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study. Lancet Oncol. 2013;14:363–370. - PubMed
-
- Thakur J, Prinja S, Jeet G, Bhatnagar N. Costing of a state-wide population based cancer awareness and early detection campaign in a 2.67 million population of Punjab state in Northern India. Asian Pacific J Cancer Prev. 2016;17:791–797. - PubMed
-
- Kennedy MPT, Cheyne L, Darby M. Lung cancer stage-shift following a symptom awareness campaign. Thorax. 2018;73:1128–1136. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources